[1] |
Lakhani SR,Ellis IO,Schnitt SJ, et al. WHO classification of tumours of the breast[M].4 ed. Lyon: IARC Press,2012.
|
[2] |
Mohanty SK,Kim SA,DeLair DF, et al. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation[J].Mod Pathol,2016,29(8):788-798.
|
[3] |
Adams RW,Dyson P,Barthelmes L. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast? [J]. Breast,2014,23(2):120-127.
|
[4] |
Tavassoli FA,Devilee P. World Health Organization classification oftumours. Pathology and genetics of tumours. Pathology and genetics of tumours of the breast and femalegenital organs[M]. Lyon: IARC Press, 2003.
|
[5] |
Tang F,Wei B,Tian Z, et al. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges[J]. Histopathology,2011,59(1):106-115.
|
[6] |
van Krimpen C,Elferink A,Broodman CA, et al. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study[J].Breast,2004,13(4):329-333.
|
[7] |
Wang J,Wei B,Albarracin CT,et al. Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database [J].BMC Cancer, 2014, 14:147.
|
[8] |
Maluf HM,Koerner FC. Carcinomas of the breast with endocrine differentiation: a review[J]. Virchows Archiv,1994,425(5):449-457.
|
[9] |
Nesland JM,Lunde S,Holm R, et al. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells[J].Histol Histopathol,1987,2(1):73-77.
|
[10] |
Kawasaki T,Mochizuki K,Yamauchi H, et al. Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance[J]. J Clin Pathol,2012,65(8):699-703.
|
[11] |
Chan J,Kulke M. Targeting the mTOR signaling pathway in neuroendocrine tumors[J]. Curr Treat Options Oncol,2014,15(3):365-379.
|
[12] |
Righi L,Sapino A,Marchiò C, et al. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems[J]. Semin Diagn Pathol,2010,27(1):69-76.
|
[13] |
Asioli S,Foschini MP,Masetti R, et al. Working formulation of neuroendocrine tumors of the skin and breast[J].Endocr Pathol,2014,25(2):141-150.
|
[14] |
Bogina G,Munari E,Brunelli M et al. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome [J].Histopathology, 2016,68(3):422-432.
|
[15] |
Kawasaki T,Mochizuki K,Yamauchi H,et al. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge [J].Breast,2012,21(5),652-656.
|
[16] |
Inno A,Bogina G,Turazza M, et al. Neuroendocrine carcinoma of the breast: Current evidence and future perspectives[J].Oncologist,2016,21(1):28-32.
|
[17] |
朱坤兵,徐灿,李晓霞,等.乳腺癌分子分型与新辅助化疗效果的关系[J/CD].中华乳腺病杂志:电子版,2016,10(3):166-169.
|